Key result
Renal replacement therapy and major vascular events significantly increased annual hospital care costs, with maintenance dialysis costing £18,986 in the year of initiation compared to £403 for patients in CKD stages 1-3B.
Cohort (n=7,246)
Yes
Absolute Event Rate: 18986% vs 403%
Renal replacement therapy and major vascular events are the primary drivers of high hospital care costs in patients with moderate-to-severe chronic kidney disease.
No takes yet. Share an insight, caveat, or question.
RRT and vascular events drive high CKD hospital costs; extends observational cost data but leaves open causal effects for trials.
Kent et al. (2015) conducted a cohort in Moderate-to-severe chronic kidney disease (n=7,246). Renal replacement therapy and major vascular events vs. CKD stages 1-3B without diabetes or vascular disease was evaluated on Annual hospital care costs (in UK 2011 prices) (95% CI 18,620-19,352). Renal replacement therapy and major vascular events significantly increased annual hospital care costs, with maintenance dialysis costing £18,986 in the year of initiation compared to £403 for patients in CKD stages 1-3B.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: